On February 24, 2016, PowerSecure International, Inc., (NYSE:POWR) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with The Southern Company, a Delaware corporation (“Southern”), and PSMS Corp., a Delaware corporation and wholly-owned subsidiary of Southern (“Merger Sub”), providing for the merger of Merger Sub with and into the Company on the terms and conditions set forth in the Merger Agreement (the “Merger”), with the Company continuing as the surviving corporation in the Merger and becoming a wholly-owned subsidiary of Southern upon consummation of the Merger.
PowerSecure International, Inc. (NYSE:POWR) belongs to Industrial Goods sector. Its net profit margin is 1.00% and weekly performance is 76.57%. On last trading day company shares ended up at $18.54.
Airgas Inc. (NYSE:ARG) shareholders, during a special shareholder meeting held on 23 February, voted to approve the previously announced acquisition of Airgas, one of the leading suppliers of industrial gases and associated products and services in the United States, by Air Liquide (Euronext Paris: AI), world leader in gases, technologies and services for Industry and Health. 75.9% of the total outstanding shares of Airgas common stock and 99.5% of the total shares voted were in favor of the transaction. The affirmative vote of a simple majority of outstanding Airgas shares was required to approve the merger.
Airgas, Inc. (NYSE:ARG) shares increased 0.04% in last trading session and ended the day at $141.76. ARG Gross Margin is 56.10% and its return on assets is 5.70%. Airgas, Inc. (NYSE:ARG) quarterly performance is 2.74%.
On 25 February, Vina Concha y Toro S.A. (NYSE:VCO) shares increased 0.70% and was closed at $33.27. VCO EPS growth in last 5 year was -3.90%. Vina Concha y Toro S.A. (NYSE:VCO) year to date (YTD) performance is 8.87%.
Intellipharmaceutics International Inc. (NASDAQ:IPCI) received final approval from the U.S. Food and Drug Administration (“FDA”) of the Company’s abbreviated new drug application (“ANDA”) for levetiracetam extended-release tablets for the 500 mg and 750 mg strengths. The Company’s newly approved product is a generic equivalent for the corresponding strengths of the branded product Keppra XR® sold in the United States by UCB, Inc.
IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) ended the last trading day at $2.87. Company weekly volatility is calculated as 12.21% and price to cash ratio as 24.79. IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) showed a weekly performance of 24.78%.
Vestin Realty Mortgage II, Inc, (NASDAQ:VRTB) announced that on February 18, 2016, it received a deficiency notification from NASDAQ that it failed to maintain, for the last thirty (30) business days, a minimum of $5,000,000 in its Market Value of Publicly Held Shares to remain on the NASDAQ Global Capital Markets. The NASDAQ rules provide the Company with a compliance period of 180 calendar days in which to regain compliance.
Vestin Realty Mortgage II, Inc. (NASDAQ:VRTB) shares increased 5.69% in last trading session and ended the day at $1.30. VRTB Gross Margin is 73.50% and its return on assets is -2.30%. Vestin Realty Mortgage II, Inc. (NASDAQ:VRTB) quarterly performance is -58.73%.